Boston
An independent LDT provider
Home
About Us
Home
About Us
Learn more
Events
News
Video resources
Social media
Management Team
Careers
Contact us
Pancreatic Cancer
Home
Pancreatic Cancer
Learn more
Pancreatic cancer staging
Importance of early detection
Risk factors and symptoms
The IMMray® PanCan-d test
Home
The IMMray® PanCan-d test
Learn more
Accuracy and contraindications
Who should be tested?
Testing frequency
Testing process
Sample collection and shipment instructions
Test results
General FAQs
Test Cost
Patients
Home
Patients
Learn more
Talking with your physician
Getting tested
Receiving the results
Additional resources
Patient FAQs
Healthcare Professionals
Home
Healthcare Professionals
Learn more
Who should be tested?
Testing frequency and counseling patients
Testing your patient
Receiving and communicating results
Healthcare professionals
Receiving and communicating results
Learn more
Receiving the results
Clinical studies
Investigator-initiated studies (IIS)
Additional resources
HCP FAQs
Investors
Pay My Bill
Provider Portal
Test Requisition
News
May 1, 2023
Immunovia AB appoints new CEO
March 1, 2023
Immunovia appoints Karl Stone as new Chief Operating Officer to...
January 17, 2023
Immunovia Appoints Lara E. Sucheston-Campbell as Head of Clinical and ...
December 5, 2022
Immunovia strengthens US organization to continue commercialization...
October 17, 2022
Immunovia launches a strategic partnership with Proteomedix to...
September 26, 2022
Centers for Medicare & Medicaid Services issues preliminary...
August 11, 2022
Immunovia, Inc. Issued Laboratory License from California Dept of...
June 27, 2022
PanFAM-1 Results Partly Inconclusive
May 23, 2022
Immunovia, Inc. market access increases when achieving Clinical...
May 17, 2022
Immunovia, Inc. achieves Clinical Laboratory Licensure from Rhode...
1
2
3
>
News
